| Homo sapiens |
Cytochrome P450 1A2 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2C19 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2C9 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2D6 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Delta opioid receptor |
Ki |
38.0 |
nM |
10.1016/j.bmcl.2009.02.078 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
F |
24.0 |
% |
10.1016/j.bmc.2007.08.060 |
| Homo sapiens |
Kappa opioid receptor |
EC50 |
11.0 |
nM |
10.1016/j.bmcl.2009.02.078 |
| Homo sapiens |
Kappa opioid receptor |
Emax |
78.0 |
% |
10.1016/j.bmcl.2009.02.078 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
10.1016/j.bmcl.2009.02.078 |
| Homo sapiens |
Kappa opioid receptor |
Imax |
nan |
None |
10.1016/j.bmcl.2009.02.078 |
| Homo sapiens |
Kappa opioid receptor |
Ki |
2.8 |
nM |
10.1016/j.bmcl.2009.02.078 |
| Homo sapiens |
Liver microsomes |
Activity |
nan |
None |
10.1021/tx300075j |
| Homo sapiens |
Liver microsomes |
Stability |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Mu opioid receptor |
EC50 |
2.6 |
nM |
10.1016/j.bmcl.2009.02.078 |
| Homo sapiens |
Mu opioid receptor |
Emax |
70.0 |
% |
10.1016/j.bmcl.2009.02.078 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
10.1016/j.bmcl.2009.02.078 |
| Homo sapiens |
Mu opioid receptor |
Imax |
nan |
None |
10.1016/j.bmcl.2009.02.078 |
| Homo sapiens |
Mu opioid receptor |
Ki |
0.28 |
nM |
10.1016/j.bmcl.2009.02.078 |
| Homo sapiens |
Skin |
log Kp |
-8.13 |
None |
10.1016/j.bmc.2007.07.050 |
| Homo sapiens |
Solute carrier family 22 member 1 |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
FC |
1.7 |
None |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
FC |
1.9 |
None |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
FC |
2.0 |
None |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
IC50 |
137970.0 |
nM |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
Km |
56100.0 |
nM |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 1 |
Vmax |
33.0 |
pmol/min/mg |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 3 |
Km |
755000.0 |
nM |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
Solute carrier family 22 member 3 |
Vmax |
672.5 |
pmol/min/mg |
10.1021/acs.jmedchem.9b01301 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-10 |
Activity |
0.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-3 |
Activity |
14.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-8 |
Activity |
29.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 1-8 |
Activity |
33.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Activity |
118.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Activity |
530.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Activity |
617.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Activity |
856.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Activity |
1028.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
UDP-glucuronosyltransferase 2B7 |
Activity |
1550.0 |
pm/min/mg |
10.1146/annurev.pharmtox.40.1.581 |
| Homo sapiens |
Whole blood |
Retention_time |
1.84 |
min |
10.1007/s00044-012-9977-1 |
| Mus musculus |
Mus musculus |
ED50 |
0.08 |
mg.kg-1 |
10.1021/jm00350a019 |
| Mus musculus |
Mus musculus |
ED50 |
0.25 |
uM |
10.1021/jm00176a012 |
| Mus musculus |
Mus musculus |
ED50 |
0.25 |
umol.kg-1 |
10.1021/jm00138a015 |
| Mus musculus |
Mus musculus |
ED50 |
0.25 |
umol.kg-1 |
10.1021/jm00176a013 |
| Mus musculus |
Mus musculus |
ED50 |
0.25 |
umol.kg-1 |
10.1021/jm00186a025 |
| Mus musculus |
Mus musculus |
ED50 |
0.25 |
umol.kg-1 |
10.1021/jm00361a019 |
| Mus musculus |
Mus musculus |
ED50 |
0.3 |
umol.kg-1 |
10.1021/jm00144a015 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
1.3 |
umol.kg-1 |
10.1021/jm00138a015 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
1.3 |
umol.kg-1 |
10.1021/jm00144a015 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
1.34 |
uM |
10.1021/jm00176a012 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
1.34 |
umol.kg-1 |
10.1021/jm00176a013 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
1.34 |
umol.kg-1 |
10.1021/jm00186a025 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
78.0 |
nmol |
10.1021/acs.jmedchem.5b00841 |
| None |
ADMET |
CL |
28.0 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Cmax |
40.0 |
nM |
10.1021/acs.jmedchem.9b01301 |
| None |
ADMET |
fCmax |
0.03 |
uM |
10.1021/acs.jmedchem.9b01301 |
| None |
ADMET |
fCmax |
0.72 |
uM |
10.1021/acs.jmedchem.9b01301 |
| None |
ADMET |
MRT |
2.6 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
2.3 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
4.3 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
5.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
Fu |
0.86 |
None |
10.1124/dmd.108.020479 |
| None |
No relevant target |
Peff |
1.7 |
ucm/s |
10.1021/acs.jmedchem.9b01301 |
| None |
No relevant target |
Solubility |
500000.0 |
nM |
10.1016/j.bmcl.2010.10.068 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b01301 |
| None |
Unchecked |
Ratio |
0.0002 |
None |
10.1021/acs.jmedchem.9b01301 |
| None |
Unchecked |
Ratio |
0.005 |
None |
10.1021/acs.jmedchem.9b01301 |
| None |
Unchecked |
Ratio Ki |
10.0 |
None |
10.1016/j.bmcl.2009.02.078 |
| None |
Unchecked |
Ratio Ki |
136.0 |
None |
10.1016/j.bmcl.2009.02.078 |